NMTR

9 Meters Biopharma Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

NMTR price

9 Meters Biopharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NMTR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NMTR

Valuation

P/E

0.00

Sector -3.53

Industry -3.53

P/BV

0.00

Sector 2.06

Industry 2.06

P/Revenue (PSR)

Sector 2.02

Industry 2.02

EV/EBITDA

Sector -222.67

Industry -222.67

EV/EBIT

Sector -47.57

Industry -47.57

P/EBITDA

Sector -21.45

Industry -21.45

P/EBIT

Sector -28.49

Industry -28.49

P/Total Assets

Sector 1.20

Industry 1.20

P/Net Current Assets

Sector -10.32

Industry -10.32

P/Working Capital

Sector -169.93

Industry -169.93

EPS

-5.06

Sector -1.79

Industry -1.79

BVPS

-0.46

Sector 2.05

Industry 2.05

Efficiency

Gross Margin

0.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

0.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

0.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

1,091.65%

Sector -56.67%

Industry -56.67%

ROA

-738.37%

Sector -59.91%

Industry -59.91%

ROIC

Sector -2,349.21%

Industry -2,349.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.88

Industry 2.88

Net Debt / EBITDA

Sector -14,043,974.86

Industry -14,043,974.86

Net Debt / EBIT

Sector -8.02

Industry -8.02

Net Debt / Equity

Sector -32,936.86

Industry -32,936.86

Gross Debt / Equity

Sector -0.84

Industry -0.84

Equity/Assets

-0.68

Sector 0.46

Industry 0.46

Liabilities/Assets

1.68

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

13.33%

Sector -

Industry -

Fundamentals NMTR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NMTR 9 Meters Biopharma Inc.	$0.00	-	0.00%	0.00	0.00	1,091.65%	0.00%
JNJ Johnson & Johnson	$264.37	51.83%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.50	23.30%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$263.69	24.63%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$42.73	-19.34%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$143.48	80.02%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$163.21	6.36%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.76	44.55%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$73.56	-49.41%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$378.12	40.58%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$779.26	36.63%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$106.73	38.79%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$896.58	26.67%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$514.66	30.45%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$232.56	54.70%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.76	31.52%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$41.09	26.86%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NMTR Historical Dividends

current DY: 0.00%

5-year average DY: 54.10%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/27/2024	07/29/2024	0.20000000
Dividends	03/21/2024	04/25/2024	0.20000000
Dividends	12/22/2023	01/26/2024	0.20000000
Dividends	09/19/2023	10/26/2023	0.30000000
Dividends	06/14/2023	07/26/2023	0.30000000
Dividends	03/16/2023	04/26/2023	0.40000000
Dividends	12/23/2022	01/26/2023	0.25440000
Dividends	09/22/2022	10/26/2022	0.01280000
Dividends	06/23/2022	07/25/2022	0.25600000
Dividends	03/22/2022	04/25/2022	0.25600000
Dividends	12/23/2021	01/25/2022	0.27200000
Dividends	09/21/2021	10/25/2021	0.27200000
Dividends	06/22/2021	07/26/2021	0.27200000
Dividends	03/23/2021	04/26/2021	0.27200000
Dividends	12/15/2020	01/25/2021	0.08000000
Dividends	09/22/2020	10/26/2020	0.06400000
Dividends	06/29/2020	07/27/2020	0.04000000
Dividends	12/18/2019	01/27/2020	0.80000000
Dividends	09/17/2019	10/25/2019	0.80000000
Dividends	06/20/2019	07/25/2019	0.80000000
Dividends	03/27/2019	04/25/2019	0.80000000
Dividends	12/12/2018	01/25/2019	0.80000000
Dividends	09/25/2018	10/26/2018	0.80000000
Dividends	06/26/2018	07/26/2018	0.80000000
Dividends	03/27/2018	04/26/2018	0.80000000
Dividends	12/14/2017	01/25/2018	0.80000000
Dividends	09/21/2017	10/25/2017	0.80000000
Dividends	06/22/2017	07/25/2017	0.80000000
Dividends	03/23/2017	04/25/2017	0.80000000
Dividends	12/23/2016	01/26/2017	0.96000000
Dividends	09/22/2016	10/28/2016	0.96000000

ABOUT 9 Meters Biopharma

9 Meters Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

16 years

Founded: 2010

2016

Time since IPO - 10 years

12

Employees

9 Meters Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-6.30 million.

The company employs approximately 12 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, 9 Meters Biopharma Inc. reported $- in revenue, generating net income of $-68.76 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NMTR.

Market cap

Net worth

$-6.30 million

$-6,299,205.00

Assets

$9.31 million

$9,313,037.00

Total Shares Outstanding

13.59 million

13,591,000

Average Daily Trading Volume

$808.94 Thousand

$808,940.22

Sector

Health Care

Industry

Biotechnology

NMTR

NMTR revenue and profits

Financial Results NMTR

DRAG THE FRAME TO SEE MORE DATA

NMTR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$896.58 28,21% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$232.56 56,73% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$264.37 52,40% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$263.69 25,04% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$143.48 83,99% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$163.21 6,85% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.50 22,78% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$896.58 28,21% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$232.56 56,73% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$264.37 52,40% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$263.69 25,04% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$143.48 83,99% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$163.21 6,85% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.50 22,78% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of 9 Meters Biopharma (NMTR) today?

A cotação de 9 Meters Biopharma (NMTR) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de 9 Meters Biopharma (NMTR) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de 9 Meters Biopharma (NMTR) e dados de ações do Ibovespa e mercados internacionais.

Quando 9 Meters Biopharma (NMTR) paga dividendos?

9 Meters Biopharma (NMTR) não distribuiu dividendos no último ano.

Is 9 Meters Biopharma (NMTR) a good investment?

Atualmente, 9 Meters Biopharma (NMTR) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de -4% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy 9 Meters Biopharma (NMTR) stock?

Investir em ações de 9 Meters Biopharma (NMTR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of 9 Meters Biopharma (NMTR) yield today?

A rentabilidade de 9 Meters Biopharma (NMTR) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de 9 Meters Biopharma (NMTR) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NMTR

9 Meters Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NMTR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING NMTR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 54.10%

type

Ex - Dividend Date

payment date

value

ABOUT 9 Meters Biopharma

9 Meters Biopharma Inc.

United States

16 years

2016

12

PROFIT X PRICE NMTR

Financial Results NMTR

NMTR cash flow

Asset, Revenue and Profit Growth - NMTR

NMTR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions